Where does Chemours's cash flow data come from?

Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Chemours CC Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	-$385M-548%	$86M+136%	-$237M-141%	$578M-5.1%
Depreciation and amortization	$340M+16.4%	$292M-5.5%	$309M+5.8%	$292M-7.3%
Stock-based compensation	$21M+40.0%	$15M-16.7%	$18M-33.3%	$27M-20.6%
Deferred income taxes	——	-$33M+76.9%	-$143M-815%	$20M+126%
Amortization of debt issuance costs	$11M-8.3%	$12M+33.3%	$9M0.0%	$9M0.0%
Impairment charges	$32M—	——	$95M—	——
Gain (loss) on sale of assets	——	——	——	$21M—
Change in accounts payable	——	$4M—	——	——
Change in other assets	-$70M-171%	$98M—	——	$96M+1,300%
Change in other liabilities	$280M+2,445%	$11M+267%	$3M-97.8%	$138M+97.1%
Other working capital changes	——	——	$1M—	——
Pension and postretirement benefit expense	——	$6M-33.3%	$9M0.0%	$9M+50.0%
Loss on extinguishment of debt	——	-$1M—	——	——
Change in receivables	-$106M—	——	——	-$91M—
Distributions from equity method investments	——	——	-$11M—	——
Net cash from operating activities	$264M—	——	$556M-26.4%	$755M-7.2%
Capital expenditures	$213M-40.8%	$360M-2.7%	$370M+20.5%	$307M+10.8%
Proceeds from sale of businesses	——	——	$143M—	——
Net cash from investing activities	-$206M+41.6%	-$353M—	——	-$284M-229%
Dividends paid	$78M-47.3%	$148M-0.7%	$149M-3.2%	$154M-6.1%
Repurchases of common stock	——	——	$69M-86.1%	$495M+186%
Proceeds from issuance of debt	——	$606M-6.5%	$648M—	$0-100%
Proceeds from issuance of common stock	——	$9M-52.6%	$19M-62.7%	$51M+122%
Payments for finance leases	$14M+16.7%	$12M+9.1%	$11M0.0%	$11M+10.0%
Taxes paid for net share settlement	——	——	——	——
Payment of debt issuance costs	——	——	——	$1M—
Net cash from financing activities	-$126M—	——	$177M+126%	-$686M-23.8%
Effect of exchange rate changes on cash	$29M—	——	——	——
Net increase (decrease) in cash	——	——	$503M—	——
Interest paid	$251M-6.0%	$267M+19.7%	$223M+36.0%	$164M-8.9%
Income taxes paid	$74M-9.8%	$82M+30.2%	$63M-51.9%	$131M-12.1%
Non-cash interest expense	$11M-8.3%	$12M+33.3%	$9M0.0%	$9M0.0%
Defined Benefit Plan Contributions	——	$12M+20.0%	$10M0.0%	$10M-41.2%
Gain (Loss) on Disposition of Assets	——	——	——	$21M—
Income Loss From Equity Method Investments Net Of Dividends Or Distributions	——	——	-$11M—	——
Increase (Decrease) in Accounts and Notes Receivable	-$106M—	——	——	-$91M—
Increase Decrease In Inventories And Other Operating Assets	$115M—	——	——	$294M+40.0%
Current liabilities	-$3M—	——	$660M+1,504%	-$47M-148%
Other long-term liabilities	$280M+2,445%	$11M+267%	$3M-97.8%	$138M+97.1%
Restructuring charges, net of cash paid (Note 15)	$32M—	——	$95M—	——
Payments for (Proceeds from) Derivative Instrument, Investing Activities	——	-$2M—	——	-$3M—
Proceeds From Life Insurance Policies	——	——	——	——
Proceeds from disposition of property, plant and equipment/other	——	——	$143M—	——
Finance Lease, Principal Payments	$14M+16.7%	$12M+9.1%	$11M0.0%	$11M+10.0%
Payments Of Debt Extinguishment Costs	——	——	——	——
Payments Of Debt Issuance Costs	——	——	——	$1M—
Payments To Supplier Financing Programs	$88M-13.7%	$102M+17.2%	$87M-17.9%	$106M+24.7%
Proceeds from issuances of debt	——	$606M-6.5%	$648M—	$0-100%
Proceeds From Payments To Minority Shareholders	——	-$1M-200%	$1M+200%	-$1M0.0%
Proceeds From Supplier Financing Programs	$80M-14.0%	$93M-24.4%	$123M+17.1%	$105M+15.4%
Repayments Of Long Term Debt Excluding Lines Of Credit	$787M+60.6%	$490M+75.0%	$280M+312%	$68M-92.0%
Income Taxes Paid, Net	$74M-9.8%	$82M+30.2%	$63M-51.9%	$131M-12.1%
Free cash flow	——	——	——	$448M-16.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Chemours's cash flow data come from?: Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.